1Bae E A,Choo M K,Park E K,et al.Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity[J].Biol Pharm Bull,2002,25:743-747.
2Sung J H,Hasegawa H,Matsumiya S,et al.Metabolism of ginseng saponins by human intestinal bacteria[J].Korean J Pharmacoge,1995,26:360-367.
3Hasegawa H,Matsumiya S,Uchiyama M,et al.Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities[J].Planta Med,1995,60:240-243.
4HasegawaH,Sung J H,Huh J D.Ginseng intestinal bacteria metabolite IH-901 as a new antimetastatic agent[J].Arch Pharm Res,1997,20:539-544.
5Hasegawa H,Suzuki R,Nagaoka T,et al.Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol[J].Biol Pharm Bull,2002,25:861-866.
6Lee B H,Lee S J,Hur J H,et al.In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria[J].Planta Med,1998,64:500-503.
7Lee S J,Ko W G,Kim J H,et al.Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease[J].Biochem Pharmacol,2000,60:677-685.
8Howe H L,Wingo P A,Thun M J,et al.Annual report to the nation on the status of cancer (1973-1998),featuring cancers with recent increasing trends[J].J Natl Cancer Inst,2001,93:824-842.
9Ogunbiyi J O.Hepatocellular carcinoma in the developing world[J].Semin Oncol,2001,28:179-187.
10Attele S A,Wu J A,Yuan C S.Ginseng pharmacology,multiple constitutes and multiple actions[J].Biochem Pharmacol,1999,58:1685-1693.
